Gordon McVie Notice

17/02/2021

It is with enormous sadness that we advise the death of our Chairman, Professor John Gordon McVie BSc (Hons), MBChB, M.D., FRCP, FRCPE, FRCPSGlas, FMedSci, DSc on 20th January 2021. Gordon was a well recognised and endeared figure in the world of cancer research and care.

In addition to being Chairman of ORIL he was a visiting professor, King’s College London, UK, Senior Clinical Research Consultant at the Italian Institute for Molecular Oncology (IFOM) Milan, and Non-Executive Director at Ellipses Pharma Ltd, UK and Chair of the European Alliance for Personalised Medicine.

After 40 years of clinical research, over 350 publications and positions with some of the leading global cancer organisations, he leaves a significant impact on the world making it a better place.

His significant achievements in the world of cancer are only surpassed by his kindness, enthusiasm and his love for family and friends. A truly brilliant man.

While ORIL makes the necessary arrangements for a suitable replacement, the CEO, Dr Philip Marshall will assume the role of Acting Chairman.

ORIL Board of Directors

Address

Registered Office
Oncology Research International Limited
Level 5, 45 St George Terrace,
Perth WA 6000 Australia